Korean journal of ophthalmology : KJO最新文献

{"title":"A case of Birdshot Chorioretinopathy successfully treated with Adalimumab.","authors":"Young Kun Suh, Se Joon Woo","doi":"10.3341/kjo.2024.0134","DOIUrl":"https://doi.org/10.3341/kjo.2024.0134","url":null,"abstract":"","PeriodicalId":101356,"journal":{"name":"Korean journal of ophthalmology : KJO","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145194271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Intraoperative and postoperative suprachoroidal hemorrhage in pediatric patients undergoing penetrating keratoplasty or Ahmed valve implantation.","authors":"Se Hee Min, Young Kook Kim, Joo Youn Oh","doi":"10.3341/kjo.2025.0079","DOIUrl":"https://doi.org/10.3341/kjo.2025.0079","url":null,"abstract":"<p><strong>Purpose: </strong>This retrospective case series aims to characterize the ocular findings, clinical presentation, management, and outcomes of suprachoroidal hemorrhage (SCH) in pediatric patients undergoing penetrating keratoplasty (PK) or Ahmed glaucoma valve (AGV) implantation.</p><p><strong>Methods: </strong>From 2012 to 2023, a total of 58 pediatric patients underwent PK, and 89 underwent AGV implantation at our institution. Among these, three perioperative SCH cases were identified. Medical records, anterior segment photographs, and ultrasonographic images of these patients were reviewed.</p><p><strong>Results: </strong>All three patients had Peters anomaly, congenital glaucoma (CG), and aniridia in both eyes. In Case 1 with Peters anomaly, CG, and partial aniridia, SCH developed intraoperatively in an aphakic eye during the third PK. In Case 2 with Peters anomaly, CG, and total aniridia, SCH was observed one day after PK and lensectomy. In Case 3 with Peters anomaly, CG, and partial aniridia, SCH occurred two days after AGV implantation in a pseudophakic eye with prior PK and cataract surgery. SCH resolved with conservative management in all cases. However, Cases 1 and 2 ultimately lost light perception, while Case 3 achieved a best-corrected visual acuity of 0.06.</p><p><strong>Conclusion: </strong>The risk of intraoperative and delayed SCH should be considered in eyes with Peters anomaly, CG, and aniridia during intraocular surgeries that involve significant intraocular pressure fluctuations.</p>","PeriodicalId":101356,"journal":{"name":"Korean journal of ophthalmology : KJO","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145194297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical features of Leber's hereditary optic neuropathy carrying a rare m.13051G>A mtDNA mutation.","authors":"Hyuna Kim, Hee Kyung Yang, Moon-Woo Seong, Jeong-Min Hwang","doi":"10.3341/kjo.2025.0086","DOIUrl":"https://doi.org/10.3341/kjo.2025.0086","url":null,"abstract":"","PeriodicalId":101356,"journal":{"name":"Korean journal of ophthalmology : KJO","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145126719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Factors Affecting Visual Outcome After Small Lenticule Extraction Pro® (VISUMAX 800).","authors":"Muhammad Irfan Kamaruddin, Ucok Parlindungan Pasaribu, Tjahyono Darminto Gondhowiardjo","doi":"10.3341/kjo.2025.0040","DOIUrl":"https://doi.org/10.3341/kjo.2025.0040","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to report factors affected visual outcome after small incision lenticule extraction (SMILE) in the early experience of treating eyes with VISUMAX 800 (Carl Zeiss Meditec AG).</p><p><strong>Methods: </strong>This is a retrospective study with cross-sectional design of eyes underwent SMILE Pro® using VISUMAX 800 in JEC @Kedoya Eye Hospital Jakarta, Indonesia. Patients 40 years old or younger with the corrected distance visual acuity (CDVA) of >20/25, manifest refractive spherical equivalent (SE) ≤10.0 diopters (D), cylinder refraction <5.0 D were included. Evaluation of visual outcome was conducted at 1 day and 1 month postoperatively. All statistical analyses were performed using the SPSS v. 26.0 software (IBM Corp.) based on data normality.</p><p><strong>Results: </strong>A total of 258 eyes from 132 patients were analyzed. 94% of eyes achieve uncorrected distance visual acuity (UDVA) 20/20 1-month post operatively. 81% of high myopic eye achieve UDVA 20/20 following by 97% and 99% in moderate and low myopic eyes, respectively. Spherical equivalent refraction (SER) (r = 0.273; p < 0.01), optic zone (OZ) (r = 0.260; p < 0.01), cap thickness (r = 0.209; p < 0.01), and residual stromal thickness (RST) (r = 0.256; p < 0.01) showed a statistically significant but weak correlation with UDVA 1 month postoperatively. There is increasing risk to get <20/20 UDVA in right eyes (OR 3.101; p<0.045), eyes with high myopia (OR 9.964; p<0.01), 100µm cap thickness (OR 4.578; p<0.01), ≤ 6mm OZ (OR 10.556; p<0.01), and <300µm RST (OR 9.100; p<0.01) 1-month post operatively.</p><p><strong>Conclusions: </strong>SMILE Pro® give promising visual outcome in early post operative period. Low-moderate myopia give better visual outcome than high myopia patient. Small OZ, thin cap thickness, and low RST could increase risk for not getting a maximum visual outcome after SMILE. Study with prospective design and longer follow up time which included comprehensive variables were needed to fully understand factors affecting VA after SMILE.</p>","PeriodicalId":101356,"journal":{"name":"Korean journal of ophthalmology : KJO","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145115752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical Efficacy of Electrical Auricular Transcutaneous Stimulation for Dry Eye: A sham-controlled, Randomized Trial.","authors":"Yeon Ji Jo, Jae Hyun Kim, Jong Soo Lee","doi":"10.3341/kjo.2025.0087","DOIUrl":"https://doi.org/10.3341/kjo.2025.0087","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to evaluate the clinical efficacy of low-frequency ear transcutaneous stimulation (TS) for improving ocular symptoms and signs in patients with dry eye disease (DED). The primary outcome was the Ocular Surface Disease Index (OSDI) score difference between TS and sham groups, while secondary outcomes included tear break-up time (TBUT), Schirmer's test (SM tube), and corneal staining (National Eye Institute [NEI] score).</p><p><strong>Methods: </strong>Patients with a tear film break-up time (TBUT) < 5 s and tear volume by Schirmer's test < 5 mm, along with ocular symptoms, were randomized into a TS treatment group (n=25) and a sham group (n=24). The TS treatment device was applied bilaterally twice daily for 8 weeks, with each session lasting 30 minutes. The ocular surface disease index (OSDI) questionnaire score, corneal and conjunctival stain score (National Eye Institute [NEI]), TBUT, and tear secretion volume (SM tube) were analyzed at baseline and 4 and 8 weeks after treatment.</p><p><strong>Results: </strong>The sham group showed no significant changes in any parameters at 4 and 8 weeks. The TS group demonstrated significant improvements in NEI score, TBUT, and SM tube values at both 4 and 8 weeks compared to the sham group (p= 0.002, 0.001, 0.017 at 4 weeks; p= 0.001, 0.001, and 0.001 at 8 weeks). No significant difference in OSDI was found between groups at 4 weeks (p= 0.061), but at 8 weeks, the TS group showed a significantly greater improvement (p= 0.018).</p><p><strong>Conclusion: </strong>The low-frequency ear TS device significantly improved DED symptoms and objective measures compared to the sham group. These findings support the potential of TS as a novel treatment option for DED.</p>","PeriodicalId":101356,"journal":{"name":"Korean journal of ophthalmology : KJO","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145116136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Economic Evaluation of Diabetic Retinopathy Screening in Developing Countries: A Systematic Review.","authors":"Ari Andayani, Kevin Anggakusuma Hendrawan, Yudistira, Ni Made Ari Suryathi, Titiek Ernawati","doi":"10.3341/kjo.2025.0047","DOIUrl":"https://doi.org/10.3341/kjo.2025.0047","url":null,"abstract":"","PeriodicalId":101356,"journal":{"name":"Korean journal of ophthalmology : KJO","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145115756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Corneal Epithelial Changes Following Trastuzumab Emtansine Treatment: A Case Report.","authors":"Sang A Park, Roo Min Jun, Kyung Eun Han","doi":"10.3341/kjo.2025.0083","DOIUrl":"https://doi.org/10.3341/kjo.2025.0083","url":null,"abstract":"","PeriodicalId":101356,"journal":{"name":"Korean journal of ophthalmology : KJO","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145071575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"An overview of the therapeutic applications of tinted lenses spectacles.","authors":"Masoumeh Ahadi, Afsaneh Ebrahimi, Ali Abbasi, Akmal Karimovich Matkarimov","doi":"10.3341/kjo.2025.0077","DOIUrl":"https://doi.org/10.3341/kjo.2025.0077","url":null,"abstract":"<p><p>Although tinted glasses are part of the world of fashion and beauty, these have various therapeutic applications in normal people, or those with ocular and neurological problems, which have been overlooked in some cases. This article reviews the therapeutic applications of tinted lenses.</p>","PeriodicalId":101356,"journal":{"name":"Korean journal of ophthalmology : KJO","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145071587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Bilateral Epstein-Barr Virus Keratitis Confirmed via Tear Polymerase Chain Reaction: A Case Report.","authors":"Min Ji Kang, Roo Min Jun, Kyung Eun Han","doi":"10.3341/kjo.2025.0091","DOIUrl":"https://doi.org/10.3341/kjo.2025.0091","url":null,"abstract":"","PeriodicalId":101356,"journal":{"name":"Korean journal of ophthalmology : KJO","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145071556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Outcomes of Re-Switching Anti-vascular Endothelial Growth Factor After Brolucizumab-Associated Inflammation in Age-related macular degeneration.","authors":"Young Kun Suh, Seok Hee Lee, Min Seok Kim","doi":"10.3341/kjo.2025.0008","DOIUrl":"https://doi.org/10.3341/kjo.2025.0008","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the anatomical and functional outcomes in cases of re-switching to previous anti-vascular endothelial growth factor (VEGF) agents due to intraocular inflammation (IOI) following a switch to brolucizumab in neovascular age-related macular degeneration (nAMD).</p><p><strong>Methods: </strong>This study included patients with nAMD who switched to brolucizumab and discontinued brolucizumab treatment due to IOI, with a follow-up duration of at least 6 months before and after brolucizumab treatment period. Changes in best-corrected visual acuity (BCVA), central macular thickness (CMT), central choroidal thickness (CCT), and retinal fluid on optical coherence tomography were evaluated.</p><p><strong>Results: </strong>A total of 16 eyes from 16 patients were reviewed. 12.5% of patients achieved complete fluid resolution before brolucizumab treatment, which increased to 93.8% during brolucizumab therapy. However, after switching back to other anti-VEGF agents, the proportion of patients with dry macula decreased to 37.5%. There were no statistically significant changes in BCVA, CMT, or CCT throughout the study period.</p><p><strong>Conclusions: </strong>In cases where brolucizumab treatment was discontinued due to IOI and switched back to other anti-VEGF agents, the anatomical response was insufficient, indicating the need for alternative treatment options.</p>","PeriodicalId":101356,"journal":{"name":"Korean journal of ophthalmology : KJO","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145071517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}